Add to ORKGMost adult patients with acute myeloid leukemia (AML) who have achieved complete remission (CR) after induction and consolidation chemotherapy relapse within 12-18 months with poor prospects of post-relapse survival.1,2 Ther
Complete remission (CR) in patients with acute myeloid leukaemia (AML) is the primary endpoint for t...
Various polichemotherapy regimens, including either high- or intermediate-dose Ara-C, are generally ...
Because information on management and outcome of AML relapse after allogeneic hematopoietic stem cel...
Approximately 300,000 patients in the world are diagnosed annually with acute myeloid leukemia (AML)...
Acute myeloid leukemia (AML) is the most common acute leukemia affecting adults. Disease relapse rep...
Maintenance treatment for patients with acute myeloid leukemia (AML) in remission has recently been ...
The most effective post-remission treatment to maintain complete remission (CR) in adults aged betwe...
The most effective post-remission treatment to maintain complete remission (CR) in adults aged betwe...
textabstractAcute myelogenous leukemia (AML) is characterized by both an increase in the number of w...
Relapsed/refractory acute myeloid leukemia (AML) is a devastating disease with a poor prognosis and ...
The optimal follow-up care for relapse detection in acute myeloid leukemia (AML) patients in first r...
CONTEXT: Young patients affected by acute myeloid leukemia (AML) achieve complete remission (CR) usi...
International audienceIn elderly patients with acute myeloid leukemia (AML) treated intensively, no ...
Background. There are little data from India on the management of acute myeloid leukaemia. With bett...
Adults with newly diagnosed or relapsed acute myeloid leukemia (AML) commonly receive intensive chem...
Complete remission (CR) in patients with acute myeloid leukaemia (AML) is the primary endpoint for t...
Various polichemotherapy regimens, including either high- or intermediate-dose Ara-C, are generally ...
Because information on management and outcome of AML relapse after allogeneic hematopoietic stem cel...
Approximately 300,000 patients in the world are diagnosed annually with acute myeloid leukemia (AML)...
Acute myeloid leukemia (AML) is the most common acute leukemia affecting adults. Disease relapse rep...
Maintenance treatment for patients with acute myeloid leukemia (AML) in remission has recently been ...
The most effective post-remission treatment to maintain complete remission (CR) in adults aged betwe...
The most effective post-remission treatment to maintain complete remission (CR) in adults aged betwe...
textabstractAcute myelogenous leukemia (AML) is characterized by both an increase in the number of w...
Relapsed/refractory acute myeloid leukemia (AML) is a devastating disease with a poor prognosis and ...
The optimal follow-up care for relapse detection in acute myeloid leukemia (AML) patients in first r...
CONTEXT: Young patients affected by acute myeloid leukemia (AML) achieve complete remission (CR) usi...
International audienceIn elderly patients with acute myeloid leukemia (AML) treated intensively, no ...
Background. There are little data from India on the management of acute myeloid leukaemia. With bett...
Adults with newly diagnosed or relapsed acute myeloid leukemia (AML) commonly receive intensive chem...
Complete remission (CR) in patients with acute myeloid leukaemia (AML) is the primary endpoint for t...
Various polichemotherapy regimens, including either high- or intermediate-dose Ara-C, are generally ...
Because information on management and outcome of AML relapse after allogeneic hematopoietic stem cel...